36.70
price up icon78.33%   16.12
pre-market  プレマーケット:  37.03   0.33   +0.90%
loading
前日終値:
$20.58
開ける:
$21.25
24時間の取引高:
4.83M
Relative Volume:
11.51
時価総額:
$751.57M
収益:
-
当期純損益:
$-75.86M
株価収益率:
-7.1864
EPS:
-5.1069
ネットキャッシュフロー:
$-59.39M
1週間 パフォーマンス:
+75.43%
1か月 パフォーマンス:
+115.88%
6か月 パフォーマンス:
+53.69%
1年 パフォーマンス:
+194.07%
1日の値動き範囲:
Value
$21.25
$37.58
1週間の範囲:
Value
$19.95
$37.58
52週間の値動き範囲:
Value
$9.10
$37.58

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
名前
Forte Biosciences Inc
Name
セクター
Healthcare (1100)
Name
電話
(310) 618-6994
Name
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
職員
22
Name
Twitter
Name
次回の収益日
2026-08-13
Name
最新のSEC提出書
Name
FBRX's Discussions on Twitter

Compare FBRX vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
FBRX icon
FBRX
Forte Biosciences Inc
36.70 751.57M 0 -75.86M -59.39M -5.1069
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
496.50 126.01B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
667.95 70.03B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
909.49 56.56B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
312.79 41.76B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
191.13 40.63B 742.00K -1.37B -1.07B -7.0731

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-25 開始されました Evercore ISI Outperform
2025-08-18 開始されました Guggenheim Buy
2025-01-21 開始されました TD Cowen Buy
2024-04-08 アップグレード Ladenburg Thalmann Neutral → Buy
2021-09-20 アップグレード Chardan Capital Markets Sell → Buy
2021-09-03 ダウングレード B. Riley Securities Buy → Neutral
2021-09-03 ダウングレード Chardan Capital Markets Buy → Sell
2021-09-03 ダウングレード Ladenburg Thalmann Buy → Neutral
2021-09-03 ダウングレード Truist Buy → Hold
2021-05-14 開始されました B. Riley Securities Buy
2021-03-26 開始されました Citigroup Buy
2020-08-28 アップグレード Chardan Capital Markets Neutral → Buy
2020-08-25 開始されました Truist Buy
すべてを表示

Forte Biosciences Inc (FBRX) 最新ニュース

pulisher
Jul 09, 2026

Forte Biosciences skin pigmentation disorder drug shows strong efficacy, safety in early study - MSN

Jul 09, 2026
pulisher
Jul 09, 2026

FBRX Stock Explodes Higher On Surging Momentum - timothysykes.com

Jul 09, 2026
pulisher
Jul 09, 2026

Enovix, Forte Biosciences rally premarket; PepsiCo slips By Investing.com - Investing.com South Africa

Jul 09, 2026
pulisher
Jul 09, 2026

Market movers: Forte Biosciences, Micron Technology, Simply Good Foods, PepsiCo… - Proactive financial news

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences shares surge after positive phase 1b vitiligo results - Yahoo Finance

Jul 09, 2026
pulisher
Jul 09, 2026

FBRX Stock On Track For Biggest Single-Day Gains In 20 Months – What’s Behind The Super Rally? - TradingView

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences Skin Pigmentation Disorder Drug Shows Strong Efficacy, Safety In Early Study - Benzinga

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Bio surges on trial data for vitiligo drug (FBRX:NASDAQ) - Seeking Alpha

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences Shares Climb After Positive Phase 1b Vitiligo Trial Results (FBRX) - Yahoo Finance

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences’ FB102 Shows Statistically Significant Improvement in Vitiligo in Phase 1b Trial With Strong Safety Profile – Minichart - Minichart

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences Reports Positive Phase 1b Vitiligo Results - TipRanks

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences reports positive phase 1b vitiligo trial results - Investing.com

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences stock jumps on positive vitiligo trial data - Investing.com

Jul 09, 2026
pulisher
Jul 09, 2026

Forte Biosciences reports positive Phase 1b vitiligo data for FB102 with 29.6% mean FVASI improvement - TradingView

Jul 09, 2026
pulisher
Jul 09, 2026

[8-K] Forte Biosciences, Inc. Reports Material Event - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Forte’s skin-disease drug showed measured gains through week 24 - Stock Titan

Jul 09, 2026
pulisher
Jul 08, 2026

Federated Hermes (FBRX) shows 2.11M-share, 10.31% Schedule 13G/A stake - Stock Titan

Jul 08, 2026
pulisher
Jul 07, 2026

Certain Options of Forte Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 8-JUL-2026. - marketscreener.com

Jul 07, 2026
pulisher
Jul 07, 2026

Forte Biosciences Inc focuses on dermatology pipeline as investors weigh long-term prospects - AD HOC NEWS

Jul 07, 2026
pulisher
Jul 07, 2026

FRTX to Acquire Crinetics Pharmaceuticals for $10 Billion - GuruFocus

Jul 07, 2026
pulisher
Jul 06, 2026

RSU vesting boosts holdings at Forte Biosciences (NASDAQ: FBRX) - Stock Titan

Jul 06, 2026
pulisher
Jul 03, 2026

FBRXForte Biosciences Inc Options - Finviz

Jul 03, 2026
pulisher
Jul 02, 2026

(FBRX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jul 02, 2026
pulisher
Jun 30, 2026

Enterprise value to EBIT forward of Forte Biosciences, Inc. – NASDAQ:FBRX - TradingView

Jun 30, 2026
pulisher
Jun 29, 2026

Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Forte Biosciences, Inc.(NasdaqCM:FBRX) added to Russell Microcap Growth Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell Small Cap Completeness Index - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

Forte Biosciences, Inc.(NasdaqCM: FBRX) dropped from Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 24, 2026

FBRX Q1 2026 Earnings: EPS Misses Estimates, No Revenue Reported, Stock Gains 2.15%Earnings Deceleration Risk - dars.gov.et

Jun 24, 2026
pulisher
Jun 24, 2026

Forte Biosciences Inc (FBRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 24, 2026
pulisher
Jun 24, 2026

Forte Biosciences Inc (FBRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 24, 2026
pulisher
Jun 22, 2026

Forte Biosciences Inc (FBRX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 22, 2026
pulisher
Jun 17, 2026

Forte Biosciences Inc (FBRX) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Forte Biosciences Inc (FBRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Forte Biosciences (FBRX) CFO receives 22,000 stock options grant - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Forte Biosciences (FBRX) awards 500,000 stock options to insider Wagner - Stock Titan

Jun 17, 2026
pulisher
Jun 17, 2026

Forte Biosciences Inc (FBRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Forte Biosciences Inc (FBRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Forte Biosciences Inc (FBRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026
pulisher
Jun 16, 2026

Forte Biosciences (FBRX) Dips Nearly 5%: Testing Key Support at $16.29Revenue Weighted - newsline.com

Jun 16, 2026
pulisher
Jun 13, 2026

One Forte Biosciences Insider Raised Stake By 30% In Previous Year - Yahoo Finance

Jun 13, 2026
pulisher
Jun 11, 2026

[EFFECT] Forte Biosciences, Inc. SEC Filing - Stock Titan

Jun 11, 2026
pulisher
Jun 10, 2026

FBRX Q1 2026 Earnings: Wider-than-Expected Loss as Biotech Continues DevelopmentMargin Guidance - newsline.com

Jun 10, 2026
pulisher
Jun 10, 2026

Trading Systems Reacting to (FBRX) Volatility - Stock Traders Daily

Jun 10, 2026
pulisher
Jun 10, 2026

Forte Biosciences (FBRX) Gains 5%: Support and Resistance Levels in FocusWave Extension - dars.gov.et

Jun 10, 2026
pulisher
Jun 08, 2026

Millennium Group (FBRX) reports shared control of 1,062,182 shares - Stock Titan

Jun 08, 2026
pulisher
Jun 08, 2026

Forte Biosciences | S-3/A: Registration statement for specified transactions by certain issuers (Amendment) - Moomoo

Jun 08, 2026

Forte Biosciences Inc (FBRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$118.26
price up icon 1.48%
$57.96
price down icon 0.70%
$36.81
price up icon 2.00%
$76.56
price up icon 3.74%
ONC ONC
$302.83
price up icon 0.31%
$191.13
price up icon 0.72%
大文字化:     |  ボリューム (24 時間):